Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Autocrine Signaling

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...

Autocrine Signaling

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...

Autophagy

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Tetanus

Tetanus

Tetanus is a life-threatening neurological disorder characterized by persistent muscle contractions and spastic paralysis. It is caused by Clostridium tetani, a motile, Gram-positive, rod-shaped, obligate anaerobe. These bacteria produce terminal endospores, giving them a distinctive “lollipop” or “tennis-racket” appearance. They thrive in anaerobic environments, such as those found in deep puncture wounds.Once introduced into the body, the spores germinate into vegetative cells. These cells...

Autophagic Cell Death

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Melatonin Facts: Musing With the Concept "Melatonin Travels Freely Through Biological Membranes".

Journal of pineal research·2026

Same author

Octadecaneuropeptide, ODN, Promotes Cell Survival against 6-OHDA-Induced Oxidative Stress and Apoptosis by Modulating the Expression of miR-34b, miR-29a, and miR-21in Cultured Astrocytes.

Cells·2024

Same author

Industrial and academic approaches to the search for alternative melatonin receptor ligands: An historical survey.

Journal of pineal research·2024

Same author

Melatonin facts: Melatonin lacks immuno-inflammation boosting capacities at the molecular and cellular levels.

Biochimie·2024

Same author

Polymorphisms and Pharmacogenomics of <i>NQO2</i>: The Past and the Future.

Genes·2024

Same author

Melatonin facts: Lack of evidence that melatonin is a radical scavenger in living systems.

Journal of pineal research·2023

Search research articles

Related Experiment Video

Updated: Jun 22, 2026

Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice

Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice

Published on: October 27, 2014

Autotaxin.

Jean A Boutin¹, Gilles Ferry

¹Pharmacologie Moléculaire et Cellulaire, Institut de Recherches SERVIER, Croissy-sur-Seine, France. jean.boutin@fr.netgrs.com

Cellular and Molecular Life Sciences : CMLS

|June 10, 2009

Summary

Autotaxin, a protein linked to cancer cell production, shows a strong association with metastasis. Further research may validate autotaxin as a key target for developing new oncology treatments.

Area of Science:

Biochemistry
Oncology
Molecular Biology

Background:

Autotaxin is a protein discovered in the early 1990s, with significant associations to cancer cell production observed over the last 15 years.
Recent research highlights an intimate link between autotaxin and the metastatic capacity of cancer.
The discovery of novel molecular targets in oncology is challenging, with few successfully validated for patient treatment outside the kinase domain.

Purpose of the Study:

To explore the potential of autotaxin as a therapeutic target in oncology, particularly for metastatic processes.
To leverage existing observations from diabetes and obesity research concerning the autotaxin-lysophosphatidic acid relationship for cancer applications.
To guide future experimental designs for validating autotaxin in cancer treatment strategies.

More Related Videos

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

Related Experiment Videos

Last Updated: Jun 22, 2026

Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice

Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice

Published on: October 27, 2014

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

Main Methods:

Literature review of autotaxin's role in cancer and metastasis.
Analysis of the relationship between autotaxin and lysophosphatidic acid (LPA).
Examination of findings from diabetes/obesity research for potential oncology applications.

Main Results:

A strong correlation exists between cancer cells and autotaxin production.
Autotaxin is closely implicated in the ability of cancer to metastasize.
The interplay between autotaxin and lysophosphatidic acid, observed in other metabolic contexts, offers valuable insights.

Conclusions:

Autotaxin represents a promising, yet underexplored, molecular target for anti-cancer therapies.
Repurposing findings from metabolic research may accelerate the validation of autotaxin as an oncology target.
Further investigation is warranted to fully elucidate and exploit autotaxin's role in combating cancer metastasis.